Markus‐Frederik Bohn

6.5k total citations
23 papers, 788 citations indexed

About

Markus‐Frederik Bohn is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, Markus‐Frederik Bohn has authored 23 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Virology. Recurrent topics in Markus‐Frederik Bohn's work include Venomous Animal Envenomation and Studies (7 papers), Biochemical and Structural Characterization (6 papers) and HIV Research and Treatment (5 papers). Markus‐Frederik Bohn is often cited by papers focused on Venomous Animal Envenomation and Studies (7 papers), Biochemical and Structural Characterization (6 papers) and HIV Research and Treatment (5 papers). Markus‐Frederik Bohn collaborates with scholars based in United States, Denmark and Norway. Markus‐Frederik Bohn's co-authors include Celia A. Schiffer, Shivender M.D. Shandilya, Charles S. Craik, Mohan Somasundaran, Takahide Kouno, Tania V. Silvas, Brian A. Kelch, Neşe Kurt Yılmaz, Hiroshi Matsuo and Michael A. Carpenter and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Markus‐Frederik Bohn

23 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus‐Frederik Bohn United States	12	543	222	143	135	130	23	788
D McDonald United States	15	844 1.6×	230 1.0×	167 1.2×	137 1.0×	80 0.6×	28	1.3k
Mary Jane McWilliams United States	15	557 1.0×	265 1.2×	151 1.1×	95 0.7×	92 0.7×	20	848
Nadine M. Shaban United States	15	539 1.0×	278 1.3×	96 0.7×	190 1.4×	120 0.9×	21	800
Vincent Dussupt United States	15	330 0.6×	227 1.0×	118 0.8×	98 0.7×	87 0.7×	23	693
Jean Paul Briand France	13	435 0.8×	206 0.9×	58 0.4×	97 0.7×	55 0.4×	16	781
Thomas P. Cujec United States	11	613 1.1×	490 2.2×	87 0.6×	79 0.6×	85 0.7×	16	863
Shu Mi China	12	329 0.6×	146 0.7×	77 0.5×	64 0.5×	171 1.3×	22	636
Shivender M.D. Shandilya United States	12	576 1.1×	406 1.8×	52 0.4×	212 1.6×	69 0.5×	14	881
Bojana Lucic Germany	12	805 1.5×	477 2.1×	228 1.6×	106 0.8×	115 0.9×	15	1.2k
Jean-Philippe Belzile Canada	11	270 0.5×	306 1.4×	119 0.8×	188 1.4×	47 0.4×	13	703

Countries citing papers authored by Markus‐Frederik Bohn

Since Specialization

Citations

This map shows the geographic impact of Markus‐Frederik Bohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus‐Frederik Bohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus‐Frederik Bohn more than expected).

Fields of papers citing papers by Markus‐Frederik Bohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus‐Frederik Bohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus‐Frederik Bohn. The network helps show where Markus‐Frederik Bohn may publish in the future.

Co-authorship network of co-authors of Markus‐Frederik Bohn

This figure shows the co-authorship network connecting the top 25 collaborators of Markus‐Frederik Bohn. A scholar is included among the top collaborators of Markus‐Frederik Bohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus‐Frederik Bohn. Markus‐Frederik Bohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivera‐de‐Torre, Esperanza, et al.. (2024). Discovery of broadly‐neutralizing antibodies against brown recluse spider and Gadim scorpion sphingomyelinases using consensus toxins as antigens. Protein Science. 33(3). e4901–e4901. 8 indexed citations

Rimbault, Charlotte, Shirin Ahmadi, Esperanza Rivera‐de‐Torre, et al.. (2023). Phage display assisted discovery of a pH ‐dependent anti‐α‐cobratoxin antibody from a natural variable domain library. Protein Science. 32(12). e4821–e4821. 7 indexed citations

Bohn, Markus‐Frederik, Christoffer V. Sørensen, Giang Thi Tuyet Nguyen, et al.. (2023). A comparative study of protein structure prediction tools for challenging targets: Snake venom toxins. Toxicon. 238. 107559–107559. 6 indexed citations

Sørensen, Christoffer V., José R. Almeida, Markus‐Frederik Bohn, et al.. (2023). Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A2s from three different snake genera. Toxicon. 234. 107307–107307. 8 indexed citations

Rimbault, Charlotte, Kim Boddum, Hanif Ali, et al.. (2023). A single-chain variable fragment selected against a conformational epitope of a recombinantly produced snake toxin using phage display. New Biotechnology. 76. 23–32. 11 indexed citations

Sørensen, Christoffer V., Line Ledsgaard, Markus‐Frederik Bohn, et al.. (2023). Cross-reactivity trends when selecting scFv antibodies against snake toxins using a phage display-based cross-panning strategy. Scientific Reports. 13(1). 10181–10181. 9 indexed citations

Lourenço, André Luiz, Markus‐Frederik Bohn, Byron Hann, et al.. (2023). High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions. mAbs. 15(1). 2184197–2184197. 4 indexed citations

Zhang, Ziyang, Chayanid Ongpipattanakul, Koli Basu, et al.. (2022). A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy. Cancer Cell. 40(9). 1060–1069.e7. 86 indexed citations

Jaishankar, Priyadarshini, Gregory M. Lee, Markus‐Frederik Bohn, et al.. (2022). Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine. Cell chemical biology. 29(5). 785–798.e19. 7 indexed citations

10.

Rimbault, Charlotte, Hanif Ali, Line Ledsgaard, et al.. (2022). Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes. Bioconjugate Chemistry. 33(8). 1494–1504. 22 indexed citations

11.

Sevillano, Natalia, Markus‐Frederik Bohn, Marcell Zimanyi, et al.. (2020). Structure of an affinity-matured inhibitory recombinant fab against urokinase plasminogen activator reveals basis of potency and specificity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1869(2). 140562–140562. 1 indexed citations

12.

Basu, Koli, Kwadwo Opoku-Nsiah, Victoria A. Assimon, et al.. (2019). Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases. Nature Chemical Biology. 15(8). 786–794. 59 indexed citations

13.

Kouno, Takahide, Tania V. Silvas, Brendan J. Hilbert, et al.. (2017). Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity. Nature Communications. 8(1). 15024–15024. 115 indexed citations

14.

Acker, Timothy M., Jonathan E. Gable, Markus‐Frederik Bohn, et al.. (2017). Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases. Journal of the American Chemical Society. 139(34). 11650–11653. 9 indexed citations

15.

Chen, Wuyan, Rachel Morissette, Jennifer L. Dreiling, et al.. (2016). Ehlers-Danlos Syndrome Caused by BiallelicTNXBVariants in Patients with Congenital Adrenal Hyperplasia. Human Mutation. 37(9). 893–897. 29 indexed citations

16.

Bohn, Markus‐Frederik, Shivender M.D. Shandilya, Tania V. Silvas, et al.. (2015). The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization. Structure. 23(5). 903–911. 70 indexed citations

17.

Bohn, Markus‐Frederik & Celia A. Schiffer. (2015). REdiii: a pipeline for automated structure solution. Acta Crystallographica Section D Biological Crystallography. 71(5). 1059–1067. 2 indexed citations

18.

Shandilya, Shivender M.D., Markus‐Frederik Bohn, & Celia A. Schiffer. (2014). A computational analysis of the structural determinants of APOBEC3’s catalytic activity and vulnerability to HIV-1 Vif. Virology. 471-473. 105–116. 23 indexed citations

19.

Bohn, Markus‐Frederik, Shivender M.D. Shandilya, John S. Albin, et al.. (2013). Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain. Structure. 21(6). 1042–1050. 83 indexed citations

20.

Carpenter, Michael A., Ming Li, Anurag S. Rathore, et al.. (2012). Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A. Journal of Biological Chemistry. 287(41). 34801–34808. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact